PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 100 filers reported holding PMV PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $113,400 | -16.6% | 70,000 | -12.5% | 0.01% | -20.0% |
| Q1 2024 | $136,000 | +46.2% | 80,000 | +166.7% | 0.02% | +36.4% |
| Q4 2023 | $93,000 | -49.5% | 30,000 | 0.0% | 0.01% | -52.2% |
| Q3 2023 | $184,200 | -1.9% | 30,000 | 0.0% | 0.02% | +109.1% |
| Q2 2023 | $187,800 | +57.5% | 30,000 | +20.0% | 0.01% | -26.7% |
| Q1 2023 | $119,250 | -31.5% | 25,000 | +25.0% | 0.02% | -37.5% |
| Q4 2022 | $174,000 | -99.9% | 20,000 | +100.0% | 0.02% | +41.2% |
| Q3 2022 | $119,000,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |